Patent · US Active

2,4,6-trisubstituted s-triazine compound, preparation method therefor, and use thereof

US10611736B2 · kind B2 · utility

1Cited by

0References

16Claims

0Family size

Assignee

Aluda Pharmaceuticals, Inc. · US

Inventors

Qizheng Yao · 安丰镇, CN
Jianping Wu · Shoreview, US
Ruihuan Chen · Meekrap-oord, CN
Lei Zhang · Beijing, CN
Shining Yao · 安丰镇, CN
Lian Mo · Palo Alto, US
Qingqing Zhang · Shanghai, CN

Key dates

Filing date	May 11, 2017
Grant date	Apr 7, 2020
Priority date	—
Expiry date	May 11, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a 2,4,6-trisubstituted s-triazine compound represented by general formula (I) or pharmaceutically acceptable salts, prodrugs or solvates thereof, a preparation method therefor, and use of these compounds in preparing drugs for preventing or treating diseases associated with protein kinase and vimentin dysregulation, and cell vacuolization, and in particular, drugs for treating or preventing cancer growth and metastasis, tissue fibrosis and atherosclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.